7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Zheng D et al. | The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice. | 2012 | Bone | pmid:22551876 |
| Dong W et al. | [Effect of alendronate on expressions of osteoprotegerin and receptor activator of nuclear factor κB ligand in mouse osteoblasts]. | 2012 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:23268391 |
| Terpos E et al. | Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis. | 2011 Nov-Dec | Clin. Exp. Rheumatol. | pmid:22032557 |
| Arikan F et al. | C-telopeptide pyridinoline crosslinks of type I collagen, soluble RANKL, and osteoprotegerin levels in crevicular fluid of dental implants with peri-implantitis: a case-control study. | 2011 Mar-Apr | Int J Oral Maxillofac Implants | pmid:21483881 |
| Crespi R et al. | Corticocancellous porcine bone in the healing of human extraction sockets: combining histomorphometry with osteoblast gene expression profiles in vivo. | 2011 Jul-Aug | Int J Oral Maxillofac Implants | pmid:21841997 |
| Franke S et al. | Advanced glycation end products affect growth and function of osteoblasts. | 2011 Jul-Aug | Clin. Exp. Rheumatol. | pmid:21906430 |
| Rezg R et al. | Inhibitors of vascular calcification as potential therapeutic targets. | 2011 Jul-Aug | J. Nephrol. | pmid:21688249 |
| Reyes-GarcÃa R et al. | [Cardiovascular disease and bone metabolism]. | 2011 Aug-Sep | Endocrinol Nutr | pmid:21775224 |
| Gurban CV and Mederle O | The OPG/RANKL system and zinc ions are promoters of bone remodeling by osteoblast proliferation in postmenopausal osteoporosis. | 2011 | Rom J Morphol Embryol | pmid:22119834 |
| Millard SM et al. | Blockade of receptor-activated G(i) signaling in osteoblasts in vivo leads to site-specific increases in cortical and cancellous bone formation. | 2011 | J. Bone Miner. Res. | pmid:20939063 |
| Ostrowska Z et al. | Circadian concentrations of free testosterone, selected markers of bone metabolism, osteoprotegerin and its ligand sRANKL in obese postmenopausal women. | 2011 | Postepy Hig Med Dosw (Online) | pmid:22100799 |
| Gordon IK and Camphausen K | Research highlights. | 2011 | Biomark Med | pmid:21861664 |
| Sood SK et al. | Osteoprotegerin (OPG) and related proteins (RANK, RANKL and TRAIL) in thyroid disease. | 2011 | World J Surg | pmid:21748518 |
| Stein SH and Tipton DA | Vitamin D and its impact on oral health--an update. | 2011 | J Tenn Dent Assoc | pmid:21748977 |
| Xie H et al. | Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. | 2011 | Cardiovasc. Res. | pmid:21750093 |
| Wang Y et al. | Alendronate (ALN) combined with osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats. | 2011 | J Orthop Surg Res | pmid:21752290 |
| Jabbar S et al. | Plasma vitamin D and cytokines in periodontal disease and postmenopausal osteoporosis. | 2011 | J. Periodont. Res. | pmid:20731767 |
| Lossdörfer S et al. | PTH(1-34)-induced changes in RANKL and OPG expression by human PDL cells modify osteoclast biology in a co-culture model with RAW 264.7 cells. | 2011 | Clin Oral Investig | pmid:20697756 |
| Tipton DA et al. | Effect of bisphosphonates on human gingival fibroblast production of mediators of osteoclastogenesis: RANKL, osteoprotegerin and interleukin-6. | 2011 | J. Periodont. Res. | pmid:20701670 |
| Harada S and Takahashi N | [Control of bone resorption by RANKL-RANK system]. | 2011 | Clin Calcium | pmid:21814016 |
| Nakamura M and Udagawa N | [Osteoporosis and RANKL signal]. | 2011 | Clin Calcium | pmid:21814019 |
| Persson E and Lerner UH | The neuropeptide VIP regulates the expression of osteoclastogenic factors in osteoblasts. | 2011 | J. Cell. Biochem. | pmid:21815197 |
| Üstündağ M et al. | The role of serum osteoprotegerin and S-100 protein levels in patients with acute ischaemic stroke: determination of stroke subtype, severity and mortality. | 2011 | J. Int. Med. Res. | pmid:21819709 |
| Bellido M et al. | Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis. | 2011 | Osteoarthr. Cartil. | pmid:21820069 |
| Lawrie A et al. | Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner. | 2011 | Am. J. Pathol. | pmid:21835155 |
| Poulsen MK et al. | Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus. | 2011 | Cardiovasc Diabetol | pmid:21838881 |
| Markatseli AE et al. | Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women. | 2011 | Maturitas | pmid:21840657 |
| Sudrová M et al. | Influence of long-term thromboprophylaxis with low-molecular-weight heparin (enoxaparin) on changes of bone metabolism markers in pregnant women. | 2011 | Clin. Appl. Thromb. Hemost. | pmid:20682598 |
| Mamalis AA et al. | Chemical modification of an implant surface increases osteogenesis and simultaneously reduces osteoclastogenesis: an in vitro study. | 2011 | Clin Oral Implants Res | pmid:21070383 |
| Vitoratos N et al. | Maternal circulating osteoprotegerin and soluble RANKL in pre-eclamptic women. | 2011 | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:21074311 |
| Belibasakis GN et al. | Oral biofilm challenge regulates the RANKL-OPG system in periodontal ligament and dental pulp cells. | 2011 | Microb. Pathog. | pmid:21075196 |
| Wattanaroonwong N et al. | Oestrogen inhibits osteoclast formation induced by periodontal ligament fibroblasts. | 2011 | Arch. Oral Biol. | pmid:21035111 |
| Osorio A et al. | Mineral-bone metabolism markers in young hemodialysis patients. | 2011 | Clin. Biochem. | pmid:21933667 |
| Nybo M et al. | Rosiglitazone decreases plasma levels of osteoprotegerin in a randomized clinical trial with type 2 diabetes patients. | 2011 | Basic Clin. Pharmacol. Toxicol. | pmid:21726411 |
| Fradet A et al. | Dual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin. | 2011 | Cancer Res. | pmid:21734015 |
| Campbell GM et al. | Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study. | 2011 | Osteoporos Int | pmid:20480144 |
| Kaneko K and Kawai S | [Mechanisms and therapeutics of glucocorticoid-induced osteoporosis]. | 2011 | Nihon Rinsho Meneki Gakkai Kaishi | pmid:21720102 |
| Karadag-Saygi E et al. | The effect of risedronate treatment on serum osteoprotegerin and bone marker levels in postmenopausal women with osteoporosis. | 2011 | Gynecol. Endocrinol. | pmid:21627558 |
| Taylor R et al. | Osteoclast formation and function in pigmented villonodular synovitis. | 2011 | J. Pathol. | pmid:21706481 |
| Zhang Y et al. | Study of the mechanisms by which Sambucus williamsii HANCE extract exert protective effects against ovariectomy-induced osteoporosis in vivo. | 2011 | Osteoporos Int | pmid:20414641 |
| Conaway HH et al. | Retinoids stimulate periosteal bone resorption by enhancing the protein RANKL, a response inhibited by monomeric glucocorticoid receptor. | 2011 | J. Biol. Chem. | pmid:21715325 |
| Hie M and Tsukamoto I | Vitamin C-deficiency stimulates osteoclastogenesis with an increase in RANK expression. | 2011 | J. Nutr. Biochem. | pmid:20444587 |
| El-Shehaby A et al. | Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis. | 2011 | J. Clin. Immunol. | pmid:21691937 |
| Nich C et al. | Oestrogen deficiency modulates particle-induced osteolysis. | 2011 | Arthritis Res. Ther. | pmid:21696618 |
| Belibasakis GN et al. | Porphyromonas gingivalis induces RANKL in T-cells. | 2011 | Inflammation | pmid:20446027 |
| Clézardin P | [The role of RANK/RANKL/osteoprotegerin (OPG) triad in cancer-induced bone diseases: physiopathology and clinical implications]. | 2011 | Bull Cancer | pmid:21700551 |
| Celczyńska Bajew L et al. | The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density. | 2011 | Kardiol Pol | pmid:21678294 |
| Dzida G | [Decalcified bones, calcified heart?]. | 2011 | Kardiol Pol | pmid:21678295 |
| Yang Q et al. | Plasma osteoprotegerin levels and long-term prognosis in patients with intermediate coronary artery lesions. | 2011 | Clin Cardiol | pmid:21678453 |
| Toffoli B et al. | Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop. | 2011 | Atherosclerosis | pmid:21679949 |
| de Moraes M et al. | Comparative immunohistochemical expression of RANK, RANKL and OPG in radicular and dentigerous cysts. | 2011 | Arch. Oral Biol. | pmid:21683340 |
| Roshandel D et al. | Influence of polymorphisms in the RANKL/RANK/OPG signaling pathway on volumetric bone mineral density and bone geometry at the forearm in men. | 2011 | Calcif. Tissue Int. | pmid:21964949 |
| Davenport C et al. | Identifying coronary artery disease in men with type 2 diabetes: osteoprotegerin, pulse wave velocity, and other biomarkers of cardiovascular risk. | 2011 | J. Hypertens. | pmid:21970938 |
| Miyamoto K et al. | Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization. | 2011 | J. Exp. Med. | pmid:22006978 |
| Quemerais-Durieu MA et al. | [Therapeutic innovation in osteoporosis (antisclerostin antibody and denosumab)]. | 2011 | Ann. Endocrinol. (Paris) | pmid:22008272 |
| Koo HM et al. | Elevated osteoprotegerin is associated with inflammation, malnutrition and new onset cardiovascular events in peritoneal dialysis patients. | 2011 | Atherosclerosis | pmid:22015178 |
| Cao H et al. | Dysregulated atrial gene expression of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand axis in the development and progression of atrial fibrillation. | 2011 | Circ. J. | pmid:22001292 |
| Scialla JJ et al. | Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease. | 2011 | Clin J Am Soc Nephrol | pmid:21940840 |
| Cianciolo G et al. | Effects of unfractioned heparin and low-molecular-weight heparin on osteoprotegerin and RANKL plasma levels in haemodialysis patients. | 2011 | Nephrol. Dial. Transplant. | pmid:20659908 |
| Chasseraud M et al. | Tumor necrosis factor-related apoptosis-inducing ligand and vascular calcification. | 2011 | Ther Apher Dial | pmid:21426505 |
| Duheron V et al. | Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit. | 2011 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21402940 |
| Dimitrow PP et al. | The influence of statins on levels of calcification biomarkers in patients with aortic sclerosis or mild aortic stenosis. | 2011 | J. Heart Valve Dis. | pmid:21404893 |
| Marques EA et al. | Effects of resistance and aerobic exercise on physical function, bone mineral density, OPG and RANKL in older women. | 2011 | Exp. Gerontol. | pmid:21316442 |
| Chin A et al. | Effects of medicinal herb salvia miltiorrhiza on osteoblastic cells in vitro. | 2011 | J. Orthop. Res. | pmid:21319217 |
| Mencej-BedraÄ S et al. | TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women. | 2011 | Maturitas | pmid:21411255 |
| Lee JC et al. | Role of RANK-RANKL-OPG axis in cranial suture homeostasis. | 2011 | J Craniofac Surg | pmid:21415639 |
| Mainini G et al. | Serum osteoprotegerin correlates with age and bone mass in postmenopausal, but not in fertile age women. | 2011 | Clin Exp Obstet Gynecol | pmid:22268274 |
| Riksen EA et al. | Human osteoblastic cells discriminate between 20-kDa amelogenin isoforms. | 2011 | Eur. J. Oral Sci. | pmid:22243268 |
| Yang Z et al. | [Effects of negative pressure on osteogenesis in human bone marrow-derived stroma cells cultured in vitro]. | 2011 | Zhongguo Gu Shang | pmid:22276514 |
| Altinova AE et al. | Relationship between serum osteoprotegerin, glycemic control, renal function and markers of atherosclerosis in type 2 diabetes. | 2011 | Scand. J. Clin. Lab. Invest. | pmid:21486111 |
| Mercatali L et al. | Bone metastases detection by circulating biomarkers: OPG and RANK-L. | 2011 | Int. J. Oncol. | pmid:21491082 |
| Stein SH et al. | Statins regulate interleukin-1β-induced RANKL and osteoprotegerin production by human gingival fibroblasts. | 2011 | J. Periodont. Res. | pmid:21463327 |
| Liang QQ et al. | The expression of osteoprotegerin is required for maintaining the intervertebral disc endplate of aged mice. | 2011 | Bone | pmid:21466864 |
| Honda K | Interleukin-6 and soluble interleukin-6 receptor suppress osteoclastic differentiation by inducing PGE(2) production in chondrocytes. | 2011 | J Oral Sci | pmid:21467819 |
| Moldenhauer A et al. | Interleukin 32 promotes hematopoietic progenitor expansion and attenuates bone marrow cytotoxicity. | 2011 | Eur. J. Immunol. | pmid:21469100 |
| Kim H et al. | Association between Wnt signaling pathway gene polymorphisms and bone response to hormone therapy in postmenopausal Korean women. | 2011 | Menopause | pmid:21471826 |
| Mulcahy LE et al. | RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells. | 2011 | Bone | pmid:20854946 |
| Aspenberg P et al. | Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening. | 2011 | Bone | pmid:20858557 |
| Kurnatowska I et al. | Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcification in hemodialysis patients. | 2011 | Nephron Clin Pract | pmid:20861651 |
| de Souza Faloni AP et al. | Jaw and long bone marrows have a different osteoclastogenic potential. | 2011 | Calcif. Tissue Int. | pmid:20862464 |
| Dimitri P et al. | Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signalling resulting in reduced bone mass. | 2011 | Bone | pmid:20932948 |
| Yu H et al. | Overexpression of osteoprotegerin promotes preosteoblast differentiation to mature osteoblasts. | 2011 | Angle Orthod | pmid:20936961 |
| Palaniswamy C et al. | Association of warfarin use with valvular and vascular calcification: a review. | 2011 | Clin Cardiol | pmid:21298649 |
| Bostanci N et al. | Effect of periodontal treatment on receptor activator of NF-κB ligand and osteoprotegerin levels and relative ratio in gingival crevicular fluid. | 2011 | J. Clin. Periodontol. | pmid:21261673 |
| Andersen GØ et al. | Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size. | 2011 | Heart | pmid:21270073 |
| Tsukamoto S et al. | Clinical significance of osteoprotegerin expression in human colorectal cancer. | 2011 | Clin. Cancer Res. | pmid:21270110 |
| Monnouchi S et al. | The roles of angiotensin II in stretched periodontal ligament cells. | 2011 | J. Dent. Res. | pmid:21270461 |
| Chang YH et al. | Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy. | 2011 | Metab. Clin. Exp. | pmid:21251686 |
| Bai P et al. | Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. | 2011 | Respir. Res. | pmid:22176920 |
| Piedra M et al. | "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density". | 2011 | BMC Med. Genet. | pmid:22185226 |
| Kawaguchi H | [Approach for therapeutic targets of osteoarthritis]. | 2011 | Nippon Yakurigaku Zasshi | pmid:21747205 |
| Cannon JG et al. | Follicle-stimulating hormone promotes RANK expression on human monocytes. | 2011 | Cytokine | pmid:21159522 |
| Choe JY et al. | Radiographic bone damage in chronic gout is negatively associated with the inflammatory cytokines soluble interleukin 6 receptor and osteoprotegerin. | 2011 | J. Rheumatol. | pmid:21159831 |
| Mahoney DJ et al. | TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with osteoprotegerin. | 2011 | Arthritis Rheum. | pmid:21162099 |
| Nahidi L et al. | Osteoprotegerin in pediatric Crohn's disease and the effects of exclusive enteral nutrition. | 2011 | Inflamm. Bowel Dis. | pmid:20848544 |
| Čolović M et al. | FGF-R3 and OPG expression in patient with multiple myeloma following systemic sclerosis: case report and review of the literature. | 2011 | Int. J. Hematol. | pmid:21207214 |
| Hashiguchi D et al. | Mineral trioxide aggregate solution inhibits osteoclast differentiation through the maintenance of osteoprotegerin expression in osteoblasts. | 2011 | J Biomed Mater Res A | pmid:21171155 |
| Li JY et al. | Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. | 2011 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21187391 |
| Hen K et al. | [Osteoprotegerin--a new atherosclerosis marker]. | 2011 | Pol. Merkur. Lekarski | pmid:22097184 |
| Tang Y et al. | Porphyromonas endodontalis lipopolysaccharides induce RANKL by mouse osteoblast in a way different from that of Escherichia coli lipopolysaccharide. | 2011 | J Endod | pmid:22099899 |